Pelagos Insurance Capital Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt Securities	2,830	2,752	3,634	3,294	2,308	2,530
Other Investments	607.5	485.7	201	47.5	117.1	254.1
Total Investments	3,438	3,237	3,835	3,341	2,425	2,783
Cash & Equivalents	895.4	873	743	712.4	1,222	325.1
Reinsurance Contract Assets	3,425	3,076	2,956	2,353	1,959	1,729
Deferred Acquisition Costs	1,372	1,085	877.9	786.6	515.8	403.3
Other Receivables	4,250	3,525	2,974	2,410	1,874	1,567
Net Property, Plant & Equipment	-	-	-	-	-	29.9
Other Assets	331.3	647.3	380.5	425.2	316.9	215.3
Total Assets	13,711	12,444	11,766	10,028	8,313	7,053
Unearned Premiums	5,315	4,385	3,652	3,150	2,619	2,114
Claims Reserves	2,748	2,607	3,134	2,449	2,045	1,387
Accounts Payable	2,462	2,117	1,926	1,406	1,057	947.8
Total Debt	843.5	843.2	448.9	448.2	447.5	446.9
Long-Term Leases	-	-	-	-	-	31.4
Other Liabilities	88.8	91.8	156.4	125.7	157.1	107.6
Total Liabilities	11,457	10,044	9,318	7,578	6,325	5,034
Common Stock	0.9	1	1.2	1.2	1.9	1.9
Treasury Stock	-	-	-105.5	-	-	-
Additional Paid-in Capital	1,467	1,686	2,045	2,039	2,075	2,075
Accumulated Other Comprehensive Income	15.6	37.1	4.5	-27	-100.8	-11.3
Retained Earnings	770.8	675.9	503.6	436.6	0.5	-52.1
Total Common Shareholders' Equity	2,254	2,400	2,448	2,450	1,977	2,014
Minority Interest	-	-	-	-	10.3	5.2
Shareholders' Equity	2,254	2,400	2,448	2,450	1,987	2,019
Total Liabilities & Equity	13,711	12,444	11,766	10,028	8,313	7,053
Total Debt	-	0	0	0	0	31.4
Net Cash (Debt)	-	-0	-0	-0	-0	-31.4
Net Cash Per Share	-	-	-	-	-	-0.16
Book Value	2,254	2,400	2,448	2,450	1,977	2,014
Book Value Per Share	22.05	22.48	21.18	21.43	9.92	10.05
Tangible Book Value	2,254	2,400	2,448	2,450	1,977	2,014
Tangible Book Value Per Share	22.05	22.48	21.18	21.43	9.92	10.05

SEC Filings: 10-K · 10-Q